发明名称 Chiral compounds, cholesteric and ferroelectric liquid crystal compositions comprising these chiral compounds, and liquid crystal displays comprising these liquid crystal compositions
摘要 Chiral liquid crystal compounds of the general formula (1):;in which at least one of R1 and R2 is a chiral substituent,K may be a single bond or the same as K1-5 and K1-5 denote a six-membered ring system which rings may be at least partially unsaturated, wherein the number of atoms in these rings or ring systems between the two atoms forming a part of the link to the next ring, or to one of the substituents R1 and R2, does not differ by more than one if counted in the clockwise, and in the counter-clockwise sense, starting from the same atom in each case, X1-20 denote alkyl, or alkoxy, or fluorinated alkyl, or fluorinated alkoxy groups, or atom H, or halogen atoms, mixtures comprising such chiral liquid crystal compounds, and liquid crystal displays comprising such mixtures as active ingredients.
申请公布号 US8883037(B2) 申请公布日期 2014.11.11
申请号 US201313862844 申请日期 2013.04.15
申请人 Tetragon LC Chemie AG 发明人 Haase Wolfgang;Lapanik Artsiom
分类号 C09K19/12;C09K19/52;C09K19/06;C09K19/30;C09K19/00;C07D239/02;C07D213/00;C07C69/76;C07C69/63;C07C41/00;C07C43/02;C07C43/20;C09K19/34;C09K19/04;C09K19/40 主分类号 C09K19/12
代理机构 Drinker Biddle & Reath LLP 代理人 Drinker Biddle & Reath LLP
主权项 1. A chiral liquid crystal compound of the general formula (1): in which R1=Y—(CH2)n—(O)m—(CH2)k—(O)l—(CH2)p—, or Y—(CH2)n—CH═CH—(CH2)p—(O)m—, orY—(CH2)n—CHYl—(O)m—(CH2)k—(O)l—CHY2—(CH2)p—Y3, orY—(CH2)n—CHY1—(O)m—(CH2)k—(O)l—(CH2)p—Y3, orfluorinated alkyl or fluorinated alkoxy groups where the fluorinated alkyl or fluorinated alkoxy group has from 1 to 20 carbon atoms; R2=Y3—(CH2)n—CHY4—(O)m—(CH2)k—(O)l—CHY5—(CH2)p—Y, or Y3—(CH2)n—(O)m—(CH2)k—(O)l—CHY5—(CH2)p—Y, where R2 is a chiral substituent, and R1 is a non-chiral linear or branched alkyl residue having from 6 to 25 carbon atoms, and where Y denotes, in each occurrence, and independently of each other, one of the atoms H, F, and Cl, or one of the groups —CN, —S—CN, —O—CF3, —CF3, —CO—CH3, —CiH2i+1, —O—CiCH2i+1, —CO—O—CiCH2i+1, or —O—CO—CiH2i+1; Y1 and Y2 denote, in each occurrence, and independently of each other, one of the atoms F and Cl or one of the groups —CN, —CF3, —CjH2j+1, —CO—O—CjH2j+1, —O—CO—CjH2j+1 or nonsimultaneously the atom H, or simultaneously the atom H; Y3 denotes in each occurrence, and independently of each other, one of a single bond or the atom —O—, Y4 and Y5 denote, in each occurrence, and independently of each other, one of the atoms F, Cl or one of the groups —CN, —CF3, —ChH2h+1, —O—ChH2h+1, —CO—O—ChH2h+1, —O—CO—ChH2h+1 or nonsimultaneously the atom H; n, p, k, j, i, h each assume values, independently for each of n, p, k, j, i, and h, from 0 to 7; m and l independently denote 0 or 1; and if l=m=0, then i+k+n+p is at least 6 with the proviso that Y, Y1, Y2, Y3, Y4, Y5, h, i, j, k, l, m, n, and p are chosen such that R2 is a chiral substituent having at least one center of chirality, K denotes a single bond or a six-membered ring system selected from the group consisting of cyclohexane, cyclohexene, benzene, pyridine, pyrimidine, tetrazine, 1,3,2-dioxaborinane, hexahydropyridine, hexahydropyrimidine, hexahydropyridazine, hexahydropyrazine, the isomers of hexahydrotriazine, tetrahydrooxazine, cyclobutane, cyclopentane, cycloheptane, and cyclooctane rings, and from at least partially unsaturated ring compounds derived from any of these ring compounds, wherein the number of atoms in these rings or ring systems between the two atoms forming a part of the chemical bond to the next ring, or to the substituent R1 does not differ by more than one if counted in the clockwise, and if counted in the counter-clockwise sense, starting from the same atom in each case; where A and A1 assume value 0 or 1, and in the case when K is single bond, only one of A and A1 is 0, K1-5 independently of each other denote each a six-membered ring system selected from the group consisting of benzene, pyridine, pyrimidine, tetrazine, 1,3,2-dioxaborinane, hexahydropyridine, hexahydropyrimidine, hexahydropyridazine, hexahydropyrazine, the isomers of hexahydrotriazine, tetrahydrooxazine, and of the at least partially unsaturated ring compounds derived from any of these ring compounds, X1-20 denote, independently of each other, alkyl, or alkoxy, or fluorinated alkyl, or fluorinated alkoxy groups, or the atom H, or one of the halogen atoms, or one of the alkyl, alkoxy, fluorinated alkyl, and fluorinated alkoxy groups having, in each case independently of each other, from 1 to 20 carbon atoms, wherein the outer of the consecutive rings, (the rings that carry the substituents R1 and R2, respectively), do not carry substituents in the 2, 3, 5, and 6 positions and wherein at least three consecutive rings of the rings from K1, K2, K3, K4 and K5 are aromatic or heteroaromatic rings selected independently from each other from the group of rings consisting of benzene, pyridine, pyrimidine, and tetrazine, consecutive rings meaning rings that are directly bonded to each other, with one atom which is a member of the one ring being directly bonded to one atom which is a member of the next ring.
地址 LI